Free Trial

Vera Therapeutics (VERA) SEC Filings & 10K Form

Vera Therapeutics logo
$20.39 -0.85 (-4.00%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$21.13 +0.74 (+3.65%)
As of 05/21/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vera Therapeutics SEC Filings

DateFilerForm TypeView
05/06/2025
7:00 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
3:44 PM
Vera Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:21 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
7:00 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
3:05 PM
JOHNSON DAVID LEE (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:07 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:08 PM
Grant Sean (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
3:10 PM
Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:30 AM
Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:06 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:22 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
3:24 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:59 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
3:05 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:40 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
11:15 AM
Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:35 AM
Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G
11/12/2024
9:34 AM
FMR LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13G/A
11/07/2024
7:00 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
6:49 PM
Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
Form SC 13D/A
10/31/2024
5:05 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:15 PM
Vera Therapeutics (Filer)
Form 424B5
10/29/2024
5:15 AM
Vera Therapeutics (Filer)
Form 424B5
10/28/2024
4:29 PM
Vera Therapeutics (Filer)
Form S-3ASR
10/28/2024
4:30 PM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:37 PM
SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:16 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:05 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:17 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
8:01 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:05 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:45 PM
SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:38 PM
SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:38 PM
SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:36 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:19 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:04 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:40 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:31 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:24 PM
Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
3:36 PM
Vera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
08/08/2024
7:00 AM
Vera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VERA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners